Polynovo has a distribution agreement in the UK, Sus and NZ for Suprathel ( https://polynovo.com/polynovo-acquires-exclusive-sales-and-distribution-rights-for-suprathel-in-the-uk-australia-and-new-zealand/ ) which is a fully artificial product and a direct competitor to AVH. Thus I doubt PNV would be interested in AVH
The Clinicians Speak, page-1016
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.43 |
Change
0.110(4.74%) |
Mkt cap ! $1.677B | |||
| Open | High | Low | Value | Volume |
| $2.39 | $2.45 | $2.38 | $2.896M | 1.198M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3000 | $2.41 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.43 | 9997 | 4 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |